Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aimei Health Technology CoAFJK +0.68%16 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates AFJK with a GF Score™ of 16/100. The stock has 1 warning sign investors should review. Among 109 Diversified Financial Services companies, Aimei Health Technology Co ranks worse than 917430.28% on this metric.
The historical rank and industry rank for Aimei Health Technology Co's FCF Margin % or its related term are showing as below:
AFJK's FCF Margin % is not ranked *
in the Diversified Financial Services industry.
Industry Median: 2.21 * Ranked among companies with meaningful FCF Margin % only.
Aimei Health Technology Co FCF Margin % Related Terms
Aimei Health Technology Co FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AFJK vs BRRN, RDAC, MSSAF: FCF Margin % Comparison
For the Shell Companies subindustry, Aimei Health Technology Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aimei Health Technology Co FCF Margin % vs Diversified Financial Services Industry
For the Diversified Financial Services industry and Financial Services sector, Aimei Health Technology Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Aimei Health Technology Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aimei Health Technology Co (AFJK) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Aimei Health Technology Co and its competitors. According to the industry distribution chart, Aimei Health Technology Co ranks #999999 out of 109 companies in the Diversified Financial Services industry.
Is Aimei Health Technology Co's FCF Margin % too high?
Aimei Health Technology Co's current FCF Margin % is 0.00%. Based on the distribution chart, Aimei Health Technology Co ranks #999999 out of 109 companies in the Diversified Financial Services industry, which is in the bottom quartile relative to peers. Overall, Aimei Health Technology Co has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Aimei Health Technology Co's FCF Margin % compare to BRRN and RDAC?
According to the Diversified Financial Services industry distribution chart, Aimei Health Technology Co ranks #999999 out of 109 companies for FCF Margin %. This places Aimei Health Technology Co in the lower half of its industry. The industry median FCF Margin % is 2.21. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Diversified Financial Services company?
The median FCF Margin % among Diversified Financial Services companies is 2.21, based on 109 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Aimei Health Technology Co and its competitors. For the Diversified Financial Services industry, the median FCF Margin % is 2.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aimei Health Technology Co's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aimei Health Technology Co stock overvalued right now?
Aimei Health Technology Co (AFJK) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Aimei Health Technology Co's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Aimei Health Technology Co (AFJK), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AFJK has been successfully added to your 
